Thalamic volume reduction in drug-naive patients with new-onset genetic generalized epilepsy
dc.contributor.author | Perani, S | |
dc.contributor.author | Tierney, TM | |
dc.contributor.author | Centeno, M | |
dc.contributor.author | Shamshiri, EA | |
dc.contributor.author | Yaakub, SN | |
dc.contributor.author | O'Muircheartaigh, J | |
dc.contributor.author | Carmichael, DW | |
dc.contributor.author | Richardson, MP | |
dc.date.accessioned | 2023-02-20T15:00:30Z | |
dc.date.available | 2023-02-20T15:00:30Z | |
dc.date.issued | 2017-11-18 | |
dc.identifier.issn | 0013-9580 | |
dc.identifier.issn | 1528-1167 | |
dc.identifier.uri | http://hdl.handle.net/10026.1/20481 | |
dc.description.abstract |
<jats:title>Summary</jats:title><jats:sec><jats:title>Objective</jats:title><jats:p>Patients with genetic generalized epilepsy (<jats:styled-content style="fixed-case">GGE</jats:styled-content>) have subtle morphologic abnormalities of the brain revealed with <jats:styled-content style="fixed-case">magnetic resonance imaging (MRI)</jats:styled-content>, particularly in the thalamus. However, it is unclear whether morphologic abnormalities of the brain in <jats:styled-content style="fixed-case">GGE</jats:styled-content> are a consequence of repeated seizures over the duration of the disease, or are a consequence of treatment with antiepileptic drugs (<jats:styled-content style="fixed-case">AED</jats:styled-content>s), or are independent of these factors. Therefore, we measured brain morphometry in a cohort of AED‐naive patients with <jats:styled-content style="fixed-case">GGE</jats:styled-content> at disease onset. We hypothesize that drug‐naive patients at disease onset have gray matter changes compared to age‐matched healthy controls.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We performed quantitative measures of gray matter volume in the thalamus, putamen, caudate, pallidum, hippocampus, precuneus, prefrontal cortex, precentral cortex, and cingulate in 29 AED‐naive patients with new‐onset <jats:styled-content style="fixed-case">GGE</jats:styled-content> and compared them to 32 age‐matched healthy controls. We subsequently compared the shape of any brain structures found to differ in gray matter volume between the groups.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The thalamus was the only structure to show reduced gray matter volume in AED‐naive patients with new‐onset <jats:styled-content style="fixed-case">GGE</jats:styled-content> compared to healthy controls. Shape analysis revealed that the thalamus showed deflation, which was not uniformly distributed, but particularly affected a circumferential strip involving anterior, superior, posterior, and inferior regions with sparing of medial and lateral regions.</jats:p></jats:sec><jats:sec><jats:title>Significance</jats:title><jats:p>Structural abnormalities in the thalamus are present at the initial onset of <jats:styled-content style="fixed-case">GGE</jats:styled-content> in <jats:styled-content style="fixed-case">AED</jats:styled-content>‐naive patients, suggesting that thalamic structural abnormality is an intrinsic feature of <jats:styled-content style="fixed-case">GGE</jats:styled-content> and not a consequence of <jats:styled-content style="fixed-case">AED</jats:styled-content>s or disease duration.</jats:p></jats:sec> | |
dc.format.extent | 226-234 | |
dc.format.medium | Print-Electronic | |
dc.language | en | |
dc.language.iso | eng | |
dc.publisher | Wiley | |
dc.subject | drug naive | |
dc.subject | genetic generalized epilepsy | |
dc.subject | new onset | |
dc.subject | thalamus | |
dc.subject | volumetric MRI | |
dc.title | Thalamic volume reduction in drug-naive patients with new-onset genetic generalized epilepsy | |
dc.type | journal-article | |
dc.type | Article | |
plymouth.author-url | https://www.ncbi.nlm.nih.gov/pubmed/29150855 | |
plymouth.issue | 1 | |
plymouth.volume | 59 | |
plymouth.publisher-url | http://dx.doi.org/10.1111/epi.13955 | |
plymouth.publication-status | Published | |
plymouth.journal | Epilepsia | |
dc.identifier.doi | 10.1111/epi.13955 | |
plymouth.organisational-group | /Plymouth | |
plymouth.organisational-group | /Plymouth/Faculty of Health | |
plymouth.organisational-group | /Plymouth/Faculty of Health/School of Psychology | |
plymouth.organisational-group | /Plymouth/Users by role | |
plymouth.organisational-group | /Plymouth/Users by role/Academics | |
dc.publisher.place | United States | |
dcterms.dateAccepted | 2017-10-19 | |
dc.rights.embargodate | 2023-2-21 | |
dc.identifier.eissn | 1528-1167 | |
dc.rights.embargoperiod | Not known | |
rioxxterms.versionofrecord | 10.1111/epi.13955 | |
rioxxterms.licenseref.uri | http://www.rioxx.net/licenses/all-rights-reserved | |
rioxxterms.licenseref.startdate | 2018-01 | |
rioxxterms.type | Journal Article/Review |